Skip to content

Clinical trials

Phase 1/2 Medulloblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Phase: Phase 1/2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20081
20092
20112
20122
20142
20151
20161
20191
20201
20213
20221
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Recruiting4
Active, not recruiting2
Suspended1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University4
National Cancer Institute (NCI)3
Assistance Publique Hopitaux De Marseille1
Bristol-Myers Squibb1
Centre Leon Berard1
City of Hope Medical Center1
Eli Lilly and Company1
Fundación de investigación HM1
Giselle Sholler1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma27
Glioma12
Neuroblastoma11
Ependymoma9
Central Nervous System Neoplasms8
Glioblastoma8
Recurrence8
Astrocytoma7
Brain Neoplasms6
Neuroectodermal Tumors, Primitive6

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.